Edition:
United States

Alere Inc (ALR)

ALR on New York Consolidated

40.06USD
21 Feb 2017
Change (% chg)

$-0.16 (-0.40%)
Prev Close
$40.22
Open
$40.23
Day's High
$40.66
Day's Low
$39.93
Volume
263,471
Avg. Vol
653,142
52-wk High
$54.13
52-wk Low
$31.47

ALR

Chart for ALR

About

Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals... (more)

Overall

Beta: 0.61
Market Cap(Mil.): $3,499.25
Shares Outstanding(Mil.): 87.00
Dividend: --
Yield (%): --

Financials

  ALR Industry Sector
P/E (TTM): -- 57.82 29.32
EPS (TTM): -0.88 -- --
ROI: -1.74 7.60 13.03
ROE: -5.16 11.44 14.17

Abbott pauses on deals, to focus on St. Jude integration

Abbott Laboratories said it planned to focus on slashing its debt and integrating its $25 billion acquisition of St. Jude Medical in 2017, in a break from the hectic pace of dealmaking last year

Jan 25 2017

EU mergers and takeovers (Jan 25)

BRUSSELS, Jan 25 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Jan 25 2017

BRIEF-European Commission clears Abbott acquisition of Alere

* Alere inc - "We remain highly confident that merger will close according to terms of agreement" with Abbott Source text for Eikon: Further company coverage:

Jan 25 2017

EU clears Abbott acquisition of Alere subject to divestments

BRUSSELS European Union antitrust regulators cleared Abbott Laboratories' proposed $5.8 billion acquisition of diagnostic test maker Alere on Wednesday, subject to the divestment of some of Alere's operations.

Jan 25 2017

EU clears Abbott acquisition of Alere subject to divestments

BRUSSELS, Jan 25 European Union antitrust regulators cleared Abbott Laboratories' proposed $5.8 billion acquisition of diagnostic test maker Alere on Wednesday, subject to the divestment of some of Alere's operations.

Jan 25 2017

EU mergers and takeovers (Jan 16)

BRUSSELS, Jan 16 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Jan 16 2017

Abbott seeks to abort planned acquisition of Alere

Abbott Laboratories said on Wednesday that it had moved to terminate its proposed acquisition of Alere Inc , citing a "substantial loss" in the value of the diagnostics company since they struck a deal 10 months back.

Dec 07 2016

CMS revokes Alere unit's Medicare enrollment

Diagnostic company Alere Inc said on Friday the Medicare enrollment of one of its units had been revoked effective Nov. 4 by the Centers for Medicare and Medicaid Services (CMS), which said the unit had submitted claims for 211 dead patients.

Nov 04 2016

CMS revokes Alere unit's Medicare enrollment

Diagnostic company Alere Inc said on Friday the Medicare enrollment of one of its units had been revoked effective Nov. 4 by the Centers for Medicare and Medicaid Services (CMS), which said the unit had submitted claims for 211 dead patients.

Nov 04 2016

UPDATE 2-CMS revokes Alere unit's Medicare enrollment

Nov 4 Diagnostic company Alere Inc said on Friday the Medicare enrollment of one of its units had been revoked effective Nov. 4 by the Centers for Medicare and Medicaid Services (CMS), which said the unit had submitted claims for 211 dead patients.

Nov 04 2016

More From Around the Web

Earnings vs. Estimates